5/15
11:19 am
alny
RNAi Therapeutics Market Size Expected to Reach USD 4.28 Bn by 2033 [Yahoo! Finance]
Low
Report
RNAi Therapeutics Market Size Expected to Reach USD 4.28 Bn by 2033 [Yahoo! Finance]
5/13
12:37 pm
alny
Aldevron Announces Strategic Partnership with Acuitas Therapeutics [Yahoo! Finance]
Low
Report
Aldevron Announces Strategic Partnership with Acuitas Therapeutics [Yahoo! Finance]
5/13
11:53 am
alny
Global Cell Therapy and Gene Therapy Market Report 2023-2029 [Yahoo! Finance]
Low
Report
Global Cell Therapy and Gene Therapy Market Report 2023-2029 [Yahoo! Finance]
5/7
08:37 am
alny
Alnylam Issues 2023 Corporate Responsibility Report [Yahoo! Finance]
Low
Report
Alnylam Issues 2023 Corporate Responsibility Report [Yahoo! Finance]
5/7
08:01 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its price target raised by analysts at HC Wainwright from $395.00 to $400.00. They now have a "buy" rating on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its price target raised by analysts at HC Wainwright from $395.00 to $400.00. They now have a "buy" rating on the stock.
5/7
08:00 am
alny
Alnylam Issues 2023 Corporate Responsibility Report
Low
Report
Alnylam Issues 2023 Corporate Responsibility Report
5/5
09:16 am
alny
The Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) First-Quarter Results Are Out And Analysts Have Published New Forecasts [Yahoo! Finance]
Medium
Report
The Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) First-Quarter Results Are Out And Analysts Have Published New Forecasts [Yahoo! Finance]
5/3
02:04 pm
alny
Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y [Yahoo! Finance]
Low
Report
Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y [Yahoo! Finance]
5/3
01:16 pm
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/3
08:07 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $225.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $225.00 price target on the stock.
5/2
03:02 pm
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $200.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $200.00 price target on the stock.
5/2
11:44 am
alny
Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics [Yahoo! Finance]
Low
Report
Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics [Yahoo! Finance]
5/2
08:00 am
alny
Alnylam Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Period Activity
Low
Report
Alnylam Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Period Activity
4/30
11:04 am
alny
Gear Up for Alnylam (ALNY) Q1 Earnings: Wall Street Estimates for Key Metrics [Yahoo! Finance]
Low
Report
Gear Up for Alnylam (ALNY) Q1 Earnings: Wall Street Estimates for Key Metrics [Yahoo! Finance]
4/30
07:10 am
alny
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia [Yahoo! Finance]
Low
Report
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia [Yahoo! Finance]
4/30
07:00 am
alny
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
Low
Report
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
4/30
07:00 am
alny
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
Low
Report
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
4/30
07:00 am
alny
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
Low
Report
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
4/29
02:10 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
4/23
07:04 am
alny
ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024 [Yahoo! Finance]
Low
Report
ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024 [Yahoo! Finance]
4/21
02:04 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
4/18
11:47 am
alny
Gene Therapy: Non-Viral Vectors [Forbes]
Low
Report
Gene Therapy: Non-Viral Vectors [Forbes]
4/18
08:00 am
alny
Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results
Low
Report
Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results
4/18
07:25 am
alny
ALNY ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Alnylam Pharmaceuticals, Inc.
Low
Report
ALNY ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Alnylam Pharmaceuticals, Inc.
4/17
07:25 am
alny
Levi & Korsinsky Reminds Alnylam Investors of the Ongoing Investigation into Potential Violations of Securities Laws - ALNY
Low
Report
Levi & Korsinsky Reminds Alnylam Investors of the Ongoing Investigation into Potential Violations of Securities Laws - ALNY